1. Home
  2. TOVX vs IMTE Comparison

TOVX vs IMTE Comparison

Compare TOVX & IMTE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TOVX
  • IMTE
  • Stock Information
  • Founded
  • TOVX 2001
  • IMTE 2008
  • Country
  • TOVX United States
  • IMTE Malaysia
  • Employees
  • TOVX N/A
  • IMTE N/A
  • Industry
  • TOVX Biotechnology: Pharmaceutical Preparations
  • IMTE Consumer Electronics/Appliances
  • Sector
  • TOVX Health Care
  • IMTE Consumer Staples
  • Exchange
  • TOVX Nasdaq
  • IMTE Nasdaq
  • Market Cap
  • TOVX 3.8M
  • IMTE 4.1M
  • IPO Year
  • TOVX 2006
  • IMTE N/A
  • Fundamental
  • Price
  • TOVX $0.50
  • IMTE $1.06
  • Analyst Decision
  • TOVX Hold
  • IMTE
  • Analyst Count
  • TOVX 1
  • IMTE 0
  • Target Price
  • TOVX N/A
  • IMTE N/A
  • AVG Volume (30 Days)
  • TOVX 170.1K
  • IMTE 73.3K
  • Earning Date
  • TOVX 08-12-2025
  • IMTE 07-22-2025
  • Dividend Yield
  • TOVX N/A
  • IMTE N/A
  • EPS Growth
  • TOVX N/A
  • IMTE N/A
  • EPS
  • TOVX N/A
  • IMTE N/A
  • Revenue
  • TOVX N/A
  • IMTE $123,337.00
  • Revenue This Year
  • TOVX N/A
  • IMTE N/A
  • Revenue Next Year
  • TOVX N/A
  • IMTE N/A
  • P/E Ratio
  • TOVX N/A
  • IMTE N/A
  • Revenue Growth
  • TOVX N/A
  • IMTE 4.75
  • 52 Week Low
  • TOVX $0.40
  • IMTE $0.51
  • 52 Week High
  • TOVX $7.37
  • IMTE $3.17
  • Technical
  • Relative Strength Index (RSI)
  • TOVX 45.57
  • IMTE 47.89
  • Support Level
  • TOVX $0.42
  • IMTE $1.00
  • Resistance Level
  • TOVX $0.48
  • IMTE $1.13
  • Average True Range (ATR)
  • TOVX 0.03
  • IMTE 0.10
  • MACD
  • TOVX 0.02
  • IMTE 0.01
  • Stochastic Oscillator
  • TOVX 88.67
  • IMTE 69.33

About TOVX Theriva Biologics Inc.

Theriva Biologics Inc is a clinical-stage pharmaceutical company developing a novel oncolytic adenovirus (OV) platform to address devastating cancers with high unmet needs. It is a lead clinical-stage program VCN-01, designed to break down the tumor stroma, and its preclinical-stage program VCN-11 leverages its proprietary Albumin Shield Technology to protect systemically administered oncolytic viruses from the host immune system.

About IMTE Integrated Media Technology Limited

Integrated Media Technology Ltd is engaged in the development, sale, and distribution of autostereoscopic 3D display, 3D conversion equipment, and software, development, and sale of 3D autostereoscopic technology, and the provision of 3D consultancy services. It operates through the following segments: the sale of electronic glass, sales of air-filter products, sales of Halal products, NFT, corporate, provision of consultancy and provision of new energy products and solutions.

Share on Social Networks: